Details

Product Name in the RMS: Bendamustine Accord 2.5 mg/ml Powder for concentrate for solution for infusion

MR Number: AT/H/0497/001
Date of outcome: 17.07.2014

Type of application
Level 1: Level 2: Level 3: Level 4: Level 5:	Abridged Initial Application Generic Chemical Substance Prescription Only
Active Substances	bendamustine 2,5 mg
Form	Powder for concentrate for solution for infusion/injection
MA Holder in the RMS	Accord Healthcare Limited, Sage House, 319 Pinner Road, North Harrow, Middlesex, HA1 4HF, UK
RMS	Austria
Date of last change	04.11.2020
ATC-Code	L01AA09 bendamustine

CMS Country	Domestic Product Name
Belgium
Bulgaria	Bendamustine Accord
Cyprus	BENDAMUSTINE ACCORD
Czech Republic	Bendamustine Accord 2,5 mg/ml prášek pro koncentrát pro infuzní roztok
Denmark
Estonia	Bendamustine Accord
Finland
France
Germany	Bendamustine Accord 2,5 mg/ml Pulver für ein Konzentrat zur Herstellung einer Infusionslösung
Greece	BENDAMUSTINE/ACCORD
Hungary	BENDAMUSTINE ACCORD 2,5 mg/ml por oldatos infúzióhoz való koncentrátumhoz
Iceland	Bendamustine Accord 2,5 mg/ml Stofn fyrir innrennslisþykkni, lausn
Ireland
Italy
Latvia	Bendamustine Accord 2,5 mg/ml pulveris infūziju šķīduma koncentrāta pagatavošanai
Lithuania	Bendamustine Accord 2,5 mg/ml milteliai infuzinio tirpalo koncentratui
Malta
Netherlands
Norway	Bendamustine Accord
Poland	Bendamustine Accord
Portugal
Romania	Bendamustina Accord 2,5 mg/ml pulbere pentru concentrat pentru solutie perfuzabila
Slovak Republic	Bendamustine Accord 2,5 mg/ml prášok na infúzny koncentrát
Slovenia
Spain
Sweden
United Kingdom